INTERNATIONAL PATENT: NEWAMSTERDAM PHARMA B.V. FILES APPLICATION FOR "OBICETRAPIB FOR USE IN METHODS FOR TREATING A SUBJECT HAVING HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HEFH) AND/OR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)"

GENEVA, March 30 -- NEWAMSTERDAM PHARMA B.V. (Gooimeer 2-351411 DC Naarden) filed a patent application (PCT/EP2025/076528) for "OBICETRAPIB FOR USE IN METHODS FOR TREATING A SUBJECT HAVING HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HEFH) AND/OR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)" on Sep 17, 2025. With publication no. WO/2026/062050, the details related to the patent application was published on Mar 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DAVIDSON, Michael Harvey (Gooimeer 2-351411 DC Naarden), DITMARSCH, Marc (Gooimeer 2-351411 DC Naarden), KASTELEIN, Johannes Jacob ...